Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt
Location status: Recruiting
NCT Number: NCT03778944
Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess & compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infusion of Mannitol 20% at a dose of 0.5 mg/kg to the renal graft donor after induction of anesthesia over 15 minutes.
Infusion of Dopamine at a dose of 4 microg/kg/min to the renal graft donor after induction of anesthesia till ligation of the renal artery.
Infusion of Ringer Acetate at a rate of 15 ml/kg/hr to the renal graft donor after induction of anesthesia till ligation of the renal artery.
Time frame: 7 days
Post-operative creatinine clearance level of the transplanted kidney graft is measured in ml/min
Contact information is provided by the study sponsor or research team.
Nazmy Edward Seif
Other
Renal Graft Functional Enhancement During Donor Anesthesia: A Comparative Study of 3 Modalities
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03436368
Anesthesia, Chronic Disease
Cairo, Egypt
View Trial DetailsNCT06750575
Chronic Disease, Chronic Kidney Diseases
Utrecht, Netherlands
View Trial DetailsNCT06677437
Chronic Disease, Disease Attributes
Bron, France
View Trial DetailsNCT06577805
Chronic Disease, Disease Attributes
Chengdu, Sichuan, China
View Trial Details